Literature DB >> 10914780

Orocecal transit time and bacterial overgrowth in patients with Crohn's disease.

F Castiglione1, G Del Vecchio Blanco, A Rispo, G Petrelli, G Amalfi, A Cozzolino, I Cuccaro, G Mazzacca.   

Abstract

Bacterial overgrowth is frequent in patients with Crohn's disease (CD) and can contribute to symptoms. Motility abnormalities can predispose to bacterial overgrowth. The hydrogen (H2) and methane (CH4) breath test is a sensitive and simple tool for the diagnosis of bacterial overgrowth and for the evaluation of orocecal transit time (OCTT). In this study, we investigated the prevalence of OCTT modifications and bacterial overgrowth in a series of consecutive adult patients with CD. In 43 healthy subjects and 67 patients with CD. we performed the lactulose breath test using a gas analyzer that offers the opportunity of measuring both H2 and CH4. Of the patients, 24 had undergone an ileocolic resection before the test with ablation of the ileocecal valve. At the time of the test 15 patients had active disease, whereas in 52 subjects the disease was quiescent. Fifty-seven patients and forty controls were evaluable for OCTT and bacterial overgrowth. In 10 patients and in 3 controls, no H2 or CH4 peak was recorded during the 8-hour test. Out of 57 patients, 13 (23%) were affected by bacterial overgrowth. The prevalence of bacterial overgrowth was higher in patients with previous surgery (30%) than in nonoperated patients (18%). In all patients with bacterial overgrowth, an antibiotic treatment induced a normalization of the test and an improvement of the symptoms. We observed a longer OCTT in the patients compared to controls, although this difference was not statistically significant (154 +/- 45 vs. 136 +/- 45 minutes). OCTT was significantly longer compared to controls in the 14 CD patients with previous ileocolic resection ( 180 +/- 53 vs. 136 + 45 minutes; p < 0.004). In conclusion, we found that a significant proportion of unselected patients with CD has bacterial overgrowth and prolongation of OCTT. We suggest that the modifications in OCTT in patients with CD can predispose to bacterial overgrowth. The lactulose breath test is a simple method that can be more widely used in patients with CD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10914780     DOI: 10.1097/00004836-200007000-00015

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  20 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 2.  AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review.

Authors:  Jean-Frederic Colombel; Andrea Shin; Peter R Gibson
Journal:  Clin Gastroenterol Hepatol       Date:  2018-08-09       Impact factor: 11.382

Review 3.  Gastroduodenal "Dysbiosis": a New Clinical Entity.

Authors:  Ayesha Shah; Mark Morrison; Gerald J Holtmann
Journal:  Curr Treat Options Gastroenterol       Date:  2018-12

Review 4.  Small intestinal bacterial overgrowth syndrome.

Authors:  Jan Bures; Jiri Cyrany; Darina Kohoutova; Miroslav Förstl; Stanislav Rejchrt; Jaroslav Kvetina; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

5.  Small intestinal bacterial overgrowth: a comprehensive review.

Authors:  Andrew C Dukowicz; Brian E Lacy; Gary M Levine
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-02

6.  Small intestinal bacterial overgrowth in inactive Crohn's disease: influence of thiopurine and biological treatment.

Authors:  Cristina Sánchez-Montes; Vicente Ortiz; Guillermo Bastida; Ester Rodríguez; María Yago; Belén Beltrán; Mariam Aguas; Marisa Iborra; Vicente Garrigues; Julio Ponce; Pilar Nos
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

7.  Methane production during lactulose breath test is associated with gastrointestinal disease presentation.

Authors:  Mark Pimentel; Andrew G Mayer; Sandy Park; Evelyn J Chow; Aliya Hasan; Yuthana Kong
Journal:  Dig Dis Sci       Date:  2003-01       Impact factor: 3.199

8.  Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease.

Authors:  Shirley Cohen-Mekelburg; Zaid Tafesh; Elliot Coburn; Russell Weg; Neena Malik; Colleen Webb; Hoda Hammad; Ellen Scherl; Brian P Bosworth
Journal:  Dig Dis Sci       Date:  2018-05-14       Impact factor: 3.199

9.  Small intestinal bacterial overgrowth and orocecal transit time in patients of inflammatory bowel disease.

Authors:  S V Rana; S Sharma; A Malik; J Kaur; K K Prasad; S K Sinha; K Singh
Journal:  Dig Dis Sci       Date:  2013-05-07       Impact factor: 3.199

10.  Small intestinal bacterial overgrowth mimicking acute flare as a pitfall in patients with Crohn's Disease.

Authors:  Jochen Klaus; Ulrike Spaniol; Guido Adler; Richard A Mason; Max Reinshagen; Christian von Tirpitz C
Journal:  BMC Gastroenterol       Date:  2009-07-30       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.